rood blauwe elepsis logo Belegger.nl

Amerikaanse aandelen Terug naar discussie overzicht

Cannabis aandelen

8.267 Posts
Pagina: «« 1 ... 339 340 341 342 343 ... 414 »» | Laatste | Omlaag ↓
  1. forum rang 10 DeZwarteRidder 9 november 2019 11:24
    quote:

    Empros schreef op 9 november 2019 11:20:

    Wtf...! Aangedikt met vitamine E?
    Go and report yourself!
    Je kunt dat prima opeten, maar als damp in je longen is het heel slecht.

    Hetzelfde geldt trouwens voor asbest.
  2. Empros 9 november 2019 11:58
    Baaidewee...Op zoek naar diversificatie van je porto? Hou Alibaba (BABA) in het oog ...listing HongKong 25/11!
    Good hunting
  3. Rider 12 november 2019 09:23
    quote:

    DeZwarteRidder schreef op 12 november 2019 00:15:

    [...]
    De verwachtingen zijn duidelijk te hoog.
    Alefia staat nog zeer goedkoop tegenover andere cannabisaandelen.
  4. Rider 12 november 2019 09:33
    quote:

    Osho schreef op 12 november 2019 09:15:

    Cijfers Organigram vallen tegen.
    547% meer dan in 2018 en het is nog niet goed. Mensen snappen niet dat dit een nieuwe markt is.
  5. [verwijderd] 12 november 2019 13:19
    quote:

    Rider schreef op 12 november 2019 09:33:

    [...]

    547% meer dan in 2018 en het is nog niet goed. Mensen snappen niet dat dit een nieuwe markt is.
    OGI premarket -18%. Denk dat ik nog wat ga bijkopen dan.
  6. Jezzaa 12 november 2019 13:25
    Organigram Holdings Inc. issued revenue guidance late Monday, saying that it now expects fiscal fourth-quarter net revenue of C$16.3 million ($12.3 million), a sequential decline from third-quarter revenue of C$24.8 million. Analysts polled by FactSet had expected fourth-quarter revenue of C$27.9 million. U.S. traded shares of Organigram fell more than 11% in the extended session. Organigram's fiscal fourth quarter ended in August and the revenue estimate is net of excise taxes. Organigram said it shipped about $20 million worth of cannabis during the quarter and said the lack of retail stores was partly to blame. The company said it expects to have roughly $47.9 million in cash and equivalents by the end of the quarter. "While Q4 2019 did not meet our overall expectations, we have not only emerged as one of the national leaders in the industry with significant growth expected in net revenue and strong market share, we expect to report positive adjusted EBITDA for the year," Chief Executive Greg Engel said in a statement. The company will report earnings in full Nov. 25 before the market opens and has a conference call scheduled for 8:00 a.m. Eastern time.

8.267 Posts
Pagina: «« 1 ... 339 340 341 342 343 ... 414 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.001
AB InBev 2 5.483
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.206
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.528
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.651
Aedifica 3 901
Aegon 3.258 322.670
AFC Ajax 538 7.086
Affimed NV 2 6.288
ageas 5.844 109.885
Agfa-Gevaert 14 2.048
Ahold 3.538 74.294
Air France - KLM 1.025 35.000
AIRBUS 1 11
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.036
Alfen 16 24.334
Allfunds Group 4 1.468
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 405
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.813
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.835 242.759
AMG 971 133.102
AMS 3 73
Amsterdam Commodities 305 6.686
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 485
Antonov 22.632 153.605
Aperam 92 14.936
Apollo Alternative Assets 1 17
Apple 5 380
Arcadis 252 8.731
Arcelor Mittal 2.033 320.583
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.288
Aroundtown SA 1 219
Arrowhead Research 5 9.716
Ascencio 1 26
ASIT biotech 2 697
ASMI 4.108 39.082
ASML 1.766 106.069
ASR Nederland 21 4.451
ATAI Life Sciences 1 7
Atenor Group 1 470
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.610
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.390